Wells Fargo & Company Scopus Bio Pharma Inc. Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $0.45 $4 - $9	-20 Reduced 22.47%	69 $0
Q2 2022 Aug 12, 2022	BUY	$0.36 - $0.74 $2 - $5	7 Added 8.54%	89 $0
Q1 2022 May 16, 2022	BUY	$0.6 - $1.7 $11 - $32	19 Added 30.16%	82 $0
Q4 2021 Feb 14, 2022	BUY	$1.63 - $4.28 $22 - $59	14 Added 28.57%	63 $0
Q3 2021 Nov 15, 2021	BUY	$4.0 - $6.99 $196 - $342	49 New	49 $0
Q2 2021 Aug 16, 2021	SELL	$5.17 - $10.25 $11,311 - $22,427	-2,188 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$7.94 - $14.87 $17,372 - $32,535	2,188 New	2,188 $18,000

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.